简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-07-08 18:13 New Study shows Urolithin A (Mitopure®) Improves Mitochondrial Health, Reduces Joint Cartilage Damage and Alleviates Pain in Osteoarthritis
2022-07-08 18:09 Mary Kay Inc. Partners With Dr. Jack Gilbert to Further Study Skin’s “Microbiome” and the Impact on the Aging Process
2022-07-07 19:43 KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland
2022-07-06 14:21 Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
2022-07-06 11:46 Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
2022-07-05 19:09 SINOVAC joins hands with HKU-CTC research team and Gleneagles Hospital Hong Kong to kick off a clinical trial of an Omicron-specific inactivated vaccine for booster use in Hong Kong, China
2022-07-04 11:30 Spinal Cord Stimulation Delivers Improved Arm Function
2022-07-01 17:48 Medidata Announces Rapid Expansion of its Sensor Cloud Network with the Addition of 10 Health Technology Innovators
2022-07-01 09:16 Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
2022-06-30 16:47 Global Experts and Practitioners Unite to Improve Ocean Health by Tackling Systemic Challenges in Marine Management
2022-06-30 15:16 Walgreens Boots Alliance Concludes Strategic Review and Decides to Retain Ownership of its Successful Boots Business
2022-06-29 15:17 Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine
2022-06-28 22:39 MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis
2022-06-28 18:00 Aleph Farms Hires Chief of Regulatory Affairs Ahead of Global Commercialization
2022-06-27 16:12 US FDA Approves Prestige Biopharma’s IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510
2022-06-24 18:25 AiVF Raises $25 Million in Series A Round Led by Insight Partners to Help More People Become Parents
2022-06-24 16:52 Mary Kay Inc. Presents New Findings on Pollution and Skin Health at Society for Investigative Dermatology Conference
2022-06-23 19:06 Pacific Prime Opens Its ‘Scholarship Program 2022’ for Students in Asia Pacific
2022-06-22 14:28 Galderma Announces Positive Data From Phase III Trial, Demonstrating Efficacy and Safety of nemolizumab in Patients with Prurigo Nodularis
2022-06-21 14:36 AOP Health Presents Final Results From Its CONTINUATION-PV Study - up to 7.5 Years Treatment With BESREMi® (Ropeginterferon alfa-2b) of Polycythaemia Vera Patients - at EHA 2022 Annual Meeting

Business Wire Weibo

Press Releases

Latest Releases